View in EDS HTML Full Text PDF Full Text

Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial.

Saved in:
Bibliographic Details
Title: Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial.
Authors: Dunbar J; Sage Therapeutics, Inc., Cambridge, MA, USA., Walling DP; CenExel CNS, Los Alamitos, CA, USA., Hassman HA; CenExel Hassman Research Institute, Marlton, NJ, USA., Jain R; Texas Tech University School of Medicine, Austin, TX, USA., Czysz A; Sage Therapeutics, Inc., Cambridge, MA, USA., Nandy I; Sage Therapeutics, Inc., Cambridge, MA, USA., Ona V; Sage Therapeutics, Inc., Cambridge, MA, USA., Moseley MK; Biogen, Inc., Cambridge, MA, USA., Levin S; Biogen, Inc., Cambridge, MA, USA., Maruff P; Cogstate, New Haven, CT, USA.
Source: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2024 Dec; Vol. 38 (12), pp. 1122-1136. Date of Electronic Publication: 2024 Oct 11.
Publication Type: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 8907828 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1461-7285 (Electronic) Linking ISSN: 02698811 NLM ISO Abbreviation: J Psychopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39394685
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dunbar+J%22">Dunbar J</searchLink>; Sage Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Walling+DP%22">Walling DP</searchLink>; CenExel CNS, Los Alamitos, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hassman+HA%22">Hassman HA</searchLink>; CenExel Hassman Research Institute, Marlton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Jain+R%22">Jain R</searchLink>; Texas Tech University School of Medicine, Austin, TX, USA.<br /><searchLink fieldCode="AU" term="%22Czysz+A%22">Czysz A</searchLink>; Sage Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nandy+I%22">Nandy I</searchLink>; Sage Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ona+V%22">Ona V</searchLink>; Sage Therapeutics, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Moseley+MK%22">Moseley MK</searchLink>; Biogen, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Levin+S%22">Levin S</searchLink>; Biogen, Inc., Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Maruff+P%22">Maruff P</searchLink>; Cogstate, New Haven, CT, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228907828%22">Journal of psychopharmacology (Oxford, England)</searchLink> [J Psychopharmacol] 2024 Dec; Vol. 38 (12), pp. 1122-1136. <i>Date of Electronic Publication: </i>2024 Oct 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage+Publications%22">Sage Publications </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8907828 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1461-7285 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202698811%22">02698811 </searchLink><i>NLM ISO Abbreviation: </i>J Psychopharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39394685
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/02698811241282777
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1122
    Titles:
      – TitleFull: Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dunbar J
      – PersonEntity:
          Name:
            NameFull: Walling DP
      – PersonEntity:
          Name:
            NameFull: Hassman HA
      – PersonEntity:
          Name:
            NameFull: Jain R
      – PersonEntity:
          Name:
            NameFull: Czysz A
      – PersonEntity:
          Name:
            NameFull: Nandy I
      – PersonEntity:
          Name:
            NameFull: Ona V
      – PersonEntity:
          Name:
            NameFull: Moseley MK
      – PersonEntity:
          Name:
            NameFull: Levin S
      – PersonEntity:
          Name:
            NameFull: Maruff P
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1461-7285
          Numbering:
            – Type: volume
              Value: 38
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Journal of psychopharmacology (Oxford, England)
              Type: main
ResultId 1